Application 212434
- Type
- ANDA
- Sponsor
- EUGIA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ANASTROZOLE | ANASTROZOLE | TABLET;ORAL | 1MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212434-001 | ANASTROZOLE | ANASTROZOLE | 1MG | TABLET / ORAL | AB | 2020-07-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212434-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212434-001 | ANASTROZOLE | 1MG | TABLET / ORAL | AB | 2020-07-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212434-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anastrozole | ANASTROZOLE | PD-Rx Pharmaceuticals, Inc. | 54da5c12-cfaf-7a14-e063-6394a90a3635 | 2026-06-22 | Warnings, Adverse reactions | 212434 ANDA212434 |
| Anastrozole | ANASTROZOLE | Aurobindo Pharma Limited | 71f053c2-8d0d-41a1-8630-2d797eced799 | 2025-05-19 | Warnings, Adverse reactions | 212434 ANDA212434 59651-236 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-5812 | Anastrozole | Anastrozole | A-S Medication Solutions | ANDA | Current |
| 59651-236 | Anastrozole | Anastrozole | Aurobindo Pharma Limited | ANDA | Current |